Please reload

Recent Posts

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

November 26, 2018

1/5
Please reload

Featured Posts

Frequency Therapeutics is aiming to correct hearing loss by using small molecules to reactivate progenitor cells in vivo

January 18, 2017

 

NOW HEAR THIS
By Lauren Martz, Senior Writer
Most regenerative medicine companies are using stem cell
therapies to replace and regrow damaged tissues, but development
of stem cell therapies is complicated by manufacturing and
regulatory challenges. Frequency Therapeutics Inc. is creating
a next generation approach to regenerative medicine that uses
small molecules to reactivate a patient’s dormant progenitor
cells in vivo.
The newco emerged from stealth mode last week with the
announcement of its new board of directors, which is headed
by Chairman Marc Cohen, co-founder of Cobro Ventures, and
includes serial entrepreneur and co-founder Robert Langer,
David H. Koch Institute Professor at the Massachusetts Institute
of Technology. The company has an undisclosed amount of
financing from Cobro, and a group of angel and super angel
investors. Continue reading ... pdf 

Please reload

Follow Us
Search By Tags